Minimally Invasive Glaucoma Surgery Options in Refractory Glaucoma
Current Surgery Reports · 17.11.2026 · 15 (1)
DOI: 10.1007/s40137-026-00546-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Surgery Reports, online erschienen am 17.11.2026. Verfasst von Mehmet Canleblebici. Die Arbeit nennt 56 Literaturangaben.
Abstract (Originalsprache)
Purpose of Review This review aims to evaluate the current evidence regarding the efficacy, safety, and clinical role of minimally invasive glaucoma surgery (MIGS) procedures in adult refractory open-angle glaucoma, particularly in eyes with prior failed glaucoma surgery. Recent Findings Twenty-seven studies in last decade involving Gonioscopy-assisted transluminal trabeculotomy (GATT), Trabectome, Kahook Dual Blade (KDB) goniotomy, Tanito microhook goniotomy, TRAB360, iStent, Hydrus Microstent, XEN Gel Stent, and PreserFlo MicroShunt were included. Most MIGS procedures achieved clinically meaningful reductions in intraocular pressure (IOP) and medication burden with favorable safety profiles. Angle-based procedures, including GATT, Trabectome, KDB, Tanito microhook, iStent, and Hydrus, may preserve conjunctival integrity and delay more invasive surgery. Subconjunctival devices, particularly XEN and PreserFlo, may provide greater pressure reduction in advanced or surgically complex eyes. However, bleb-dependent procedures frequently required postoperative needling, revision, or close bleb modulation. Serious vision-threatening complications were uncommon across most studies, although success rates varied widely because of different surgical indications, baseline disease severity, prior surgical history, follow-up duration, and outcome definitions. Summary MIGS may serve as a useful intermediate surgical option in carefully selected refractory glaucoma patients. These procedures may provide clinically meaningful IOP reduction with less tissue trauma, a more favourable safety profile, and preservation of conjunctival integrity compared with traditional filtering surgeries, which is particularly important in eyes with prior failed surgery, conjunctival scarring, or postoperative fibrosis and bleb-related complications. However, heterogeneity in patient selection, success definitions, follow-up duration, and study design limits direct comparison between procedures. Larger prospective studies with standardized outcome criteria are needed.
Zitieren
APA
Canleblebici, M. (2026). Minimally Invasive Glaucoma Surgery Options in Refractory Glaucoma. Current Surgery Reports, 15(1). https://doi.org/10.1007/s40137-026-00546-3
Vancouver
Canleblebici M. Minimally Invasive Glaucoma Surgery Options in Refractory Glaucoma. Current Surgery Reports. 2026;15(1). doi:10.1007/s40137-026-00546-3
BibTeX
@article{Canleblebici2026,
author = {Canleblebici, Mehmet},
title = {Minimally Invasive Glaucoma Surgery Options in Refractory Glaucoma},
journal = {Current Surgery Reports},
year = {2026},
volume = {15},
number = {1},
doi = {10.1007/s40137-026-00546-3}
}
EUVIMED